Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody.

We reported a patient who gave birth to 3 children with transient neonatal hypothyroidism. She had 3 different antibodies (Ab) to the thyrotropin receptor (TSHR) in her serum, viz., TSH binding-inhibiting (TBIAb), thyroid-stimulating (TSAb) and an additional stimulating Ab (SAb). The SAb differed from TSAb in that its in vitro stimulating effect in human thyroid and FRTL5 cells was not inhibited by TBIAb [similar data now obtained with Chinese hamster ovary (CHO) cells transfected with cloned human TSHR]. Because of symptomatic goiter enlargement the patient underwent subtotal thyroidectomy. About 50% of the gland was infiltrated with lymphocytes; thyroid follicles had columnar epithelium, despite suppression of TSH by thyroxine and the presence of the potent TBIAb. Fifteen months later, when all 3 Ab showed a decline of approximately 3 fold, she gave birth to hypothyroid twins. These data support the following conclusions: 1) thyroidectomy and immunosuppression of pregnancy do not prevent neonatal thyroid disease if TSHR Ab (TRAb) are of high titer; 2) the thyroid is not a major site of TRAb production; 3) SAb is a thyroid stimulator, distinct from TSAb in that it does not share binding epitopes on the TSHR with either TSH or TBIAb; 4) SAb was the probable cause of thyroid growth in this patient.

[1]  B. Rapoport,et al.  Autoimmune endocrinopathies 2 Recombinant thyroid autoantigens: the keys to the pathogenesis of autoimmune thyroid disease , 1993 .

[2]  T. Akamizu,et al.  Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. , 1993, The Journal of clinical endocrinology and metabolism.

[3]  A. Pinchera,et al.  Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. , 1993, The Journal of clinical endocrinology and metabolism.

[4]  B. Rapoport,et al.  Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. , 1992, The Journal of clinical endocrinology and metabolism.

[5]  J. Parma,et al.  The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.

[6]  T. Akamizu,et al.  Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. , 1992, Molecular endocrinology.

[7]  B. Rapoport,et al.  The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. , 1992, Molecular endocrinology.

[8]  J. Mckenzie,et al.  Evaluation of the biological significance of leukocyte infiltration of the thyroid in Graves' disease. , 1992, International archives of allergy and immunology.

[9]  J. Mckenzie,et al.  Autoantibodies to the TSH receptor. , 2009, Experimental and clinical endocrinology.

[10]  D. Foti,et al.  Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies. , 1991, The Journal of clinical endocrinology and metabolism.

[11]  M. Parmentier,et al.  Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies , 1990, Molecular and Cellular Endocrinology.

[12]  M. Parmentier,et al.  Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. , 1990, Biochemical and biophysical research communications.

[13]  J. Mckenzie,et al.  Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. , 1990, The Journal of clinical endocrinology and metabolism.

[14]  H. Hatabu,et al.  PRESENCE OF BOTH STIMULATING AND BLOCKING TYPES OF TSH‐RECEPTOR ANTIBODIES IN SERA FROM THREE PATIENTS WITH PRIMARY HYPOTHYROIDISM , 1990, Clinical endocrinology.

[15]  M. Parmentier,et al.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. , 1989, Biochemical and biophysical research communications.

[16]  B. Rapoport,et al.  Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. , 1989, Biochemical and biophysical research communications.

[17]  J. Mckenzie,et al.  Clinical review 3: The clinical use of thyrotropin receptor antibody measurements. , 1989, The Journal of clinical endocrinology and metabolism.

[18]  F. Hornicek,et al.  Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells. , 1986, Endocrinology.

[19]  M. Nadji,et al.  Immunoperoxidase Techniques: A Practical Approach to Tumor Diagnosis , 1986 .

[20]  S. McLachlan,et al.  TSH RECEPTOR ANTIBODY SYNTHESIS BY THYROID LYMPHOCYTES , 1986, Clinical endocrinology.

[21]  J. Mckenzie,et al.  Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease. , 1985, The Journal of clinical investigation.

[22]  J. Konishi,et al.  Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. , 1985, Annals of Internal Medicine.

[23]  P. Vitti,et al.  Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. , 1983, The Journal of clinical endocrinology and metabolism.

[24]  J. Mckenzie,et al.  Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. , 1983, The Journal of clinical investigation.

[25]  J. Mckenzie,et al.  Isoelectric focusing of thyroid-stimulating antibody of Graves' disease. , 1978, Endocrinology.